AG真人官方

ALT5 Sigma Corporation Appoints Zach Witkoff as Chairman and Welcomes Eric Trump to Board of Directors

• New leadership and strategic shift position ALT5 for accelerated growth in digital asset treasury operations
• ALT5 currently trading at mNAV of 0.92x based on market prices as of August 12, 2025

LAS VEGAS--(BUSINESS WIRE)-- ALT5 Sigma Corporation (the 鈥淐ompany,鈥� 鈥渙ur鈥� or 鈥淎LT5鈥�) (NASDAQ: ALTS) (FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions for institutions and merchants, welcomes Zach Witkoff, Co-Founder and CEO of World Liberty Financial, Inc. (鈥淲LFI鈥�), as Chairman of its board of directors (the 鈥淏oard鈥�), effective upon the closing of its previously announced $1.5 billion registered direct offering and concurrent private placement.

The previously announced financing marks the launch of ALT5鈥檚 $WLFI Treasury Strategy, through which the Company will hold approximately 7.5% of the total supply of $WLFI tokens upon the closing. WLFI is the company behind USD1, the fastest growing stablecoin in the world.

Statement from Zach Witkoff, Chairman, ALT5 Sigma Corporation:

鈥淚 am honored to assume the role of Chairman of the Board of ALT5 at such a pivotal moment in the Company鈥檚 evolution. The completion of this transaction with WLFI represents not only a significant capital infusion, but also the foundation of a bold new chapter for ALT5 鈥� one that positions the Company at the forefront of the digital asset treasury sector with a meaningful stake in the $WLFI ecosystem.

The value creation model embraced by leading Digital Asset Treasury (鈥淒AT鈥�) companies can be straightforward, yet powerful. By issuing equity at prices above multiple net asset value (鈥渕NAV鈥�) per share and using those proceeds to acquire additional digital assets, ALT5 believes that it can grow the number of tokens per share in a highly accretive manner. Over time, this per-share token growth aims to compound the Company鈥檚 intrinsic value and enhances long-term stockholder returns. Similarly, when trading below mNAV, repurchasing shares can serve as a complementary lever to drive accretion.

This disciplined mNAV accretion strategy 鈥� coupled with our substantial initial $WLFI position, and prudent capital management 鈥� provides ALT5 with tools which can help to maximize value for stockholders. The new strategy, combined with ALT5's core business - which continues to see significant growth as the demand for turnkey blockchain-payment solutions rapidly increases - underpins a long-term, value-creation engine for stockholders. While ALT5 has no current plans to access the at-the-market (鈥淎TM鈥�) facility at these mNAV levels, I expect that ALT5 will remain opportunistic in the future, evaluating token acquisitions and equity issuances only when they are expected to deliver measurable, long-term accretive benefits. At the same time, ALT5 remains committed to continuing to invest in ALT5鈥檚 innovative solutions to further strengthen its industry-leading position.

I look forward to working closely with the Board, the ALT5 management team, and all ALT5 stakeholders as ALT5 executes on this strategy and capture the tremendous opportunities that lie ahead in the rapidly expanding digital asset economy.鈥�

ALT5鈥檚 current mNAV sensitivity table can be seen below.

The appointment of Mr. Witkoff is part of a broader expansion of ALT5鈥檚 leadership team following the closing of the transaction, including the addition of Eric Trump as a Director on the Board, Zak Folkman as Board Observer, and Matt Morgan as Chief Investment Officer of the Company.

About ALT5 Sigma Corporation

ALT5 Sigma Corporation (NASDAQ:ALTS) (FRA:5AR1) is a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. ALT5 has been a constituent of the Russell Microcap Index since June 28, 2024.

Founded in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation) enables the migration to a new global financial paradigm through its suite of blockchain infrastructure technologies. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms: "ALT5 Pay" and "ALT5 Prime." The Company has processed over $5 billion USD in cryptocurrency transactions since inception.

ALT5 Pay is an award-winning cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay鈥檚 checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named 鈥淎LT5 Pro鈥� that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime鈥檚 FIX API, as well as through Broadridge Financial Solutions鈥� NYFIX gateway for approved customers.

The Company is also advancing the separation of its biotech business, which will continue under 鈥淎lyea Therapeutics Corporation.鈥� Through its biotech activities, the Company is focused on bringing to market drugs with non-addictive pain-relieving properties to treat conditions that cause chronic or severe pain. Our patented product, a novel formulation of low-dose naltrexone (JAN123), is being initially developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. The FDA has granted Jan123 Orphan Drug Designation for treatment of CRPS.

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to ALT5鈥檚 accelerated growth in digital asset treasury operations, ALT5鈥檚 holding of approximately 7.5% of the total supply of $WLFI tokens upon the closing of the offering, the positioning of the Company in the digital asset treasury sector, the belief that the Company can grow the number of tokens per share in a highly accretive manner, the belief that the intended per-share token growth aims to compound the Company鈥檚 intrinsic value and enhance long-term stockholder returns, its mNAV sensitivity analysis (including share price and token price information included therein), the Company鈥檚 potential use of its ATM facility, future token acquisitions and equity issuance or share repurchases and the benefits of the Company鈥檚 $WLFI treasury strategy, the profitability and prospective growth of ALT5鈥檚 platforms and business that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5鈥檚 services, and technology challenges for future growth or expansion, and statements regarding the Company鈥檚 potential separation plans of its biotech business. This press release also contains general statements relating to risks that the Company鈥檚 potential separation plans of its biotech business and the potential for JAN123 to treat CRPS, and other statements, including words such as 鈥渃ontinue鈥�, 鈥渆xpect鈥�, 鈥渋ntend鈥�, 鈥渨ill鈥�, 鈥渉ope鈥�, 鈥渟hould鈥�, 鈥渨ould鈥�, 鈥渕ay鈥�, 鈥減otential鈥�, and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies. This press release also contains statements that are forward-looking in respect of the expected future partial or full disposition of the Company鈥檚 interests in Alyea without specificity of the scope or methods thereof.

Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, changes in the value of WLFI tokens and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the 鈥淪EC鈥�). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled 鈥淩isk Factors鈥� in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

View source version on businesswire.com:

Media/Investor Relations Contact

[email protected]

Source: ALT5 Sigma Corporation